Fluralaner CAS#864731-61-3
CAS Number:864731-61-3
Chemical Formula:C22H17Cl2F6N3O3
Synonyms:
Fluralaner
4-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-methyl-N-(2-oxo-2-(2,2,2-trifluoroethylamino)ethyl)benzamide
Fluralaner (A1443)
Appearance:White powder
MOQ (Minimum Order Quantity):1 FCL (Full Container Load)
Fluralaner CAS#864731-61-3
Fluralaner (INN) is an orally administered systemic insecticide and acaricide. Branded Bravecto, it was approved by the FDA for flea therapy in dogs in May 2014. The European Union granted approval for this compound in February 2014, while Australia authorized its use to treat and prevent flea and tick infestations in dogs in January 2015.
Parameters
Density | 1.51±0.1 g/cm3(Predicted) |
Storage Temp | Store at -20°C |
Solubility | DMSO:150.0(Max Conc. mg/mL);269.65(Max Conc. mM) |
Form | A crystalline solid |
Pka | 12.50±0.46(Predicted) |
Color | White to off-white |
InChIKey | MLBZKOGAMRTSKP-UHFFFAOYSA-N |
Smiles | C(NCC(=O)NCC(F)(F)F)(=O)C1=CC=C(C2CC(C3=CC(Cl)=CC(Cl)=C3)(C(F)(F)F)ON=2)C=C1C |
Product Application Of Fluralaner CAS#864731-61-3
Fluralaner (864731-61-3), a novel systemic isoxazoline insecticide and acaricide, achieves prolonged efficacy via oral administration in dogs. Field research demonstrates that a single oral dose protects dogs against fleas and ticks for a minimum of 12 weeks. Its long-acting profile makes it a more user-friendly alternative to monthly tick and flea treatments, helping improve compliance and reduce the risk of vector-borne diseases.
Factory and Equipment Show
Fast delivery time
Inventory 2-3 working days New production 7-10 working days


